Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15,487 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immune responses to citrullinated and homocitrullinated peptides in healthy donors are not restricted to the HLA SE shared allele and can be selected into the memory pool.
Choudhury RH, Daniels I, Vaghela P, Atabani S, Kirk T, Symonds P, Cook KW, Al-Omari A, Weston D, Shah S, Hutchinson D, Paston SJ, Metheringham RL, Brentville VA, Durrant LG. Choudhury RH, et al. Among authors: shah s. Immunology. 2023 Aug;169(4):467-486. doi: 10.1111/imm.13645. Epub 2023 Apr 13. Immunology. 2023. PMID: 37055914
T cell repertoire to citrullinated self-peptides in healthy humans is not confined to the HLA-DR SE alleles; Targeting of citrullinated self-peptides presented by HLA-DP4 for tumour therapy.
Brentville VA, Symonds P, Cook KW, Daniels I, Pitt T, Gijon M, Vaghela P, Xue W, Shah S, Metheringham RL, Durrant LG. Brentville VA, et al. Among authors: shah s. Oncoimmunology. 2019 Feb 20;8(5):e1576490. doi: 10.1080/2162402X.2019.1576490. eCollection 2019. Oncoimmunology. 2019. PMID: 31069134 Free PMC article.
Homocitrullination of lysine residues mediated by myeloid-derived suppressor cells in the tumor environment is a target for cancer immunotherapy.
Cook KW, Xue W, Symonds P, Daniels I, Gijon M, Boocock D, Coveney C, Miles AK, Shah S, Atabani S, Choudhury RH, Vaghela P, Weston D, Metheringham RL, Brentville VA, Durrant LG. Cook KW, et al. Among authors: shah s. J Immunother Cancer. 2021 Jul;9(7):e001910. doi: 10.1136/jitc-2020-001910. J Immunother Cancer. 2021. PMID: 34321274 Free PMC article.
Citrullinated glucose-regulated protein 78 is a candidate target for melanoma immunotherapy.
Brentville VA, Symonds P, Chua J, Skinner A, Daniels I, Cook KW, Koncarevic S, Martinez-Pinna R, Shah S, Choudhury RH, Vaghela P, Weston D, Al-Omari A, Davis J, Durrant LG. Brentville VA, et al. Among authors: shah s. Front Immunol. 2022 Dec 5;13:1066185. doi: 10.3389/fimmu.2022.1066185. eCollection 2022. Front Immunol. 2022. PMID: 36544781 Free PMC article.
What do cancer-specific T cells 'see'?
Shah S, Al-Omari A, Cook KW, Paston SJ, Durrant LG, Brentville VA. Shah S, et al. Discov Immunol. 2022 Dec 6;2(1):kyac011. doi: 10.1093/discim/kyac011. eCollection 2023. Discov Immunol. 2022. PMID: 38567060 Free PMC article. Review.
Health-related quality-of-life analysis from KEYNOTE-590: pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer.
Mansoor W, Joo S, Norquist JM, Kato K, Sun JM, Shah MA, Enzinger P, Adenis A, Doi T, Kojima T, Metges JP, Li Z, Kim SB, Cho BC, Sunpaweravong P, Alsina Maqueda M, Goekkurt E, Suryawanshi S, Shah S, Shen L. Mansoor W, et al. Among authors: shah s. Oncologist. 2024 May 30:oyae087. doi: 10.1093/oncolo/oyae087. Online ahead of print. Oncologist. 2024. PMID: 38815152
15,487 results
You have reached the last available page of results. Please see the User Guide for more information.